TECregen AG is a public limited company based in Basel, founded in 2023. The company’s purpose is to develop, manufacture and distribute pharmaceutical and other healthcare products as well as develop, hold and exploit intellectual property rights in this area.
In January 2026, TECregen announced that Dr. Klaas P. Zuideveld would take over as Chief Executive Officer.
In January 2026, TECregen announced CHF 10 million in seed financing and the appointment of Dr. Bo Rode Hansen as Chairman.
| Building | B |
|---|---|
| Industry | Biotech |
| Employees | 10 |
| Founding year | 2023 |
Home 
About us 
Offer 
News 
Financial support for start-ups in Basel 
Media 
Contact 